Physician profile
Luis Blanco
NPI 1043532179
$1,917.99
in general payments reported to CMS, 2019-2025
17 companies · $615 in 2025
The $615 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $283 · 2022: $251 · 2023: $318 · 2024: $450 · 2025: $615.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,294 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,293.89 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $358.14 | 2021-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Bayer Healthcare Pharmaceuticals INC. | $243.85 | 2023-2024 | |
| Lilly USA, LLC | $237.89 | 2021-2024 | Mounjaro |
| Abiomed | $216.63 | 2025 | |
| Abbvie INC. | $132.86 | 2021-2025 | |
| Axsome Therapeutics, INC. | $131.47 | 2025 | Symbravo |
| Exact Sciences Corporation | $128.82 | 2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $116.22 | 2021-2023 | Bexsero, Pediarix, Rotarix |
| Astellas Pharma US INC | $90.00 | 2024 | |
| Horizon Therapeutics Plc | $88.99 | 2021-2022 | |
| Redhill Biopharma INC. | $40.46 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $26.00 | 2024 | Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.89 | 2025 | Jardiance |
| Genentech USA, INC. | $23.03 | 2021 | |
| Sanofi Pasteur INC. | $21.60 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ars Pharmaceuticals Operations, INC. | $20.13 | 2025 | Neffy |
| Novo Nordisk INC | $17.01 | 2023 | Rybelsus, Ozempic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Blanco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.